[Federal Register Volume 87, Number 155 (Friday, August 12, 2022)]
[Notices]
[Page 49844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17356]



[[Page 49844]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-1265]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Evaluation of the Chronic Disease Self-
Management Program in the US Affiliated Pacific Islands'' to the Office 
of Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on April 16, 2021 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Evaluation of the Chronic Disease Self-Management Program (CDSMP) 
in the US Affiliated Pacific Islands (OMB Control No. 0920-1265)--
Reinstatement--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    NCCDPHP plans to evaluate the implementation of Stanford 
University's Chronic Disease Self-Management Program (CDSMP) in the US 
Affiliated Pacific Islands (USAPIs). These jurisdictions include 
American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, 
the Republic of Palau, the Republic of the Marshall Islands, and the 
Federated States of Micronesia. Stanford University's Chronic Disease 
Self-Management Program (CDSMP) is a six-week series of workshops for 
people with arthritis, diabetes, lung disease, cancer, and other health 
problems. The workshops focus on helping participants learn strategies 
to manage chronic disease, including techniques to deal with problems 
such as frustration, fatigue, pain and isolation; appropriate exercise 
for maintaining and improving strength, flexibility, and endurance; and 
appropriate use of medications among others. Proven benefits of CDSMP 
include decreased pain and health distress, increased energy, increased 
physical activity, better communication with health care providers, and 
increased confidence in managing chronic disease. The program will be 
offered repeatedly over the course of three years. This new request is 
for three years, which will cover repeated data collection.
    The purpose of the evaluation is to understand: (1) how CDSMP is 
being implemented in the region; (2) to identify barriers and 
facilitators to implementation; (3) to monitor fidelity to Stanford 
University's model and document adaptations to the curriculum; and (4) 
to understand the self-reported effects of the program on program 
participants. Because this is the first time CDSMP is being implemented 
in the USAPIs, we do not know if the intervention, which has proven to 
improve health outcomes in many ethnic groups within the United States, 
will lead to improved health outcomes for these communities.
    CDC requests OMB approval for an estimated 63 annual burden hours. 
There are no costs to respondents other than their time to participate.
    Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Program Participant...................  Chronic Disease Self-                190               2           10/60
                                         Management
                                         Questionnaire (Pre-Post
                                         Test).
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-17356 Filed 8-11-22; 8:45 am]
BILLING CODE 4163-18-P